Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,664 | 5,319 | 7,679 | 9,007 | 8,691 |
| Other current assets | 0 | 0 | 0 | 8 | 0 |
| TOTAL | $6,246 | $5,648 | $7,930 | $9,283 | $9,524 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 150 | 12 | 12 | 12 | 8 |
| TOTAL | $150 | $12 | $12 | $12 | $8 |
| Total Assets | $6,396 | $5,660 | $7,942 | $9,294 | $9,532 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 146 |
| Accounts payable and accrued liabilities | 1,033 | 476 | 1,049 | 478 | 928 |
| Accrued Expenses | 843 | 1,158 | 1,026 | 934 | 761 |
| TOTAL | $2,015 | $1,635 | $2,075 | $1,412 | $1,834 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4,233 |
| Other Non-Current Liabilities | 0 | 0 | 3,701 | 4,095 | 0 |
| TOTAL | $N/A | $N/A | $3,701 | $4,095 | $4,233 |
| Total Liabilities | $2,015 | $1,635 | $5,776 | $5,507 | $6,068 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170 | 121 | 108 | 107 | 50 |
| Common Shares | 2 | 2 | 2 | 1 | 1 |
| Retained earnings | -85,730 | -78,605 | -71,039 | -58,809 | -48,061 |
| TOTAL | $4,381 | $4,025 | $2,166 | $3,788 | $3,465 |
| Total Liabilities And Equity | $6,396 | $5,660 | $7,942 | $9,294 | $9,532 |